Condition Aggravated in Haleon Us Holdings Llc Drugs
24 drug(s) with this reaction
21,012 total reports
Overview
Condition Aggravated has been reported as an adverse reaction across 24 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 21,012 adverse event reports mention condition aggravated in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with condition aggravated, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
Haleon Us Holdings Llc Drugs Reporting Condition Aggravated
The following Haleon Us Holdings Llc drugs have condition aggravated listed in their FDA adverse event reports, sorted by report count:
Which Haleon Us Holdings Llc drugs cause Condition Aggravated?
24 drug(s) manufactured by Haleon Us Holdings Llc have condition aggravated listed in their FDA adverse event reports: DICLOFENAC SODIUM, CALCIUM CARBONATE, FLUTICASONE PROPIONATE, DOCOSANOL, GLYCERIN, LIDOCAINE, and others.
How many Condition Aggravated reports are there for Haleon Us Holdings Llc drugs?
There are a combined 21,012 reports of condition aggravated across 24 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.